Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
BIOTRICITY INC. issued an aggregate of 1,957,297 shares of newly created Series C Preferred Stock of preferred stock to holders of Exchange Securities (Exchange Holders) for exchange of Exchange Securities consisting of common stock, options, and warrants.
- Security
- preferred stock
- Shares
- an aggregate of 1,957,297 shares of newly created Series C Preferred Stock
- Purchaser
- holders of Exchange Securities (Exchange Holders)
- Consideration
- exchange of Exchange Securities consisting of common stock, options, and warrants
Exact text from the filing
the Exchange Holders exchanged their Exchange Securities for an aggregate of 1,957,297 shares of newly created Series C Preferred Stock of the Company (on the basis of ten Exchange Securities for one share of Series C Preferred Stock).
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
BIOTRICITY INC. entered into Exchange Agreement with Holders of Exchange Securities valued at Exchange of 14,144,325 common shares, options for 3,992,427 shares, and warrants for 1,436,216 share (effective 2026-05-01).
- Action
- entry
- Counterparty
- Holders of Exchange Securities
- Value
- Exchange of 14,144,325 common shares, options for 3,992,427 shares, and warrants for 1,436,216 share
- Effective
- 2026-05-01
Exact text from the filing
On May 1, 2026, Biotricity Inc. (the “Company”) entered into exchange agreements with holders (the “Exchange Holders”) of an aggregate of 14,144,325 shares of the Company’s common stock (the “Exchange Shares”), options (the “Exchange Options”) to purchase 3,992,427 shares of common stock of the Company, and warrants (the “Exchange Warrants,” and together with the Exchange Shares and the Exchange Options, the “Exchange Securities”) to purchase 1,436,216 shares of common stock of the Company.
View on SEC.gov